GLS2 and hepatocellular carcinoma: Deletion of GCN5L1 in human HCC cell lines activated the mTORC1 pathway by enhancing glutaminolysis to promote cell proliferation, which appeared to be regulated by GCN5L1‐level‐dependent modulation of GLS1 and GLS2 acetylation and oligomerisation.